Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Telix Pharmaceuticals Ltd. ( (AU:TLX) ) is now available.
Telix Pharmaceuticals Limited has announced a change in the address of its registry office in Sydney, which is now located at Liberty Place, Level 41, 161 Castlereagh St, Sydney NSW 2000. This relocation is part of the company’s ongoing operational adjustments, reflecting its commitment to maintaining efficient administrative processes and potentially impacting its stakeholder communications.
More about Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Limited is a biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Headquartered in Melbourne, Australia, Telix operates internationally in the United States, Brazil, Canada, Europe, and Japan, with a portfolio targeting significant unmet medical needs in oncology and rare diseases.
YTD Price Performance: 14.35%
Average Trading Volume: 5,321
Technical Sentiment Signal: Strong Sell
Current Market Cap: $5.57B
See more data about TLX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue